STOCK TITAN

Limoneira Co Financials

LMNR
Source SEC Filings (10-K/10-Q) Data as of Apr 30, 2026 Currency USD FYE October

This page shows Limoneira Co (LMNR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LMNR FY2025

Thin gross margins on an asset-heavy balance sheet make cash generation highly sensitive to operating slippage.

The latest year’s deterioration was not mainly a volume story: gross margin collapse from 13.9% to 3.1% overwhelmed only modest overhead relief, pushing the company from positive to negative operating cash flow. That linkage says results here depend less on steady cost absorption than on whether a very thin gross-profit layer survives after cost of revenue.

Balance-sheet flexibility has narrowed: debt-to-equity has more than doubled in recent years while cash remained near $1.3M, so short-term needs are being met with little cash cushion. A current ratio of 1.2x suggests obligations are coverable, but only with limited room for another weak operating year.

Cash distributions look disconnected from internal generation: dividends stayed around $5.4M even as operating cash flow turned -$6.0M. With financing cash flow positive and long-term debt higher, shareholder payouts appear to have been supported by the balance sheet rather than by current-year operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 34 / 100
Financial Health Score 34/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Limoneira Co's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
14
Dilution
73
Revenue Progress
39
Burn Trend
73
Balance Sheet
4
Altman Z-Score Distress
1.39

Limoneira Co scores 1.39, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($239.7M) relative to total liabilities ($126.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
2/9

Limoneira Co passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality
0.38x

For every $1 of reported earnings, Limoneira Co generates $0.38 in operating cash flow (-$6.0M OCF vs -$16.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$159.7M
YoY-16.6%
5Y CAGR-0.6%
10Y CAGR+4.8%

Limoneira Co generated $159.7M in revenue in fiscal year 2025. This represents a decrease of 16.6% from the prior year.

EBITDA
-$11.2M
YoY-609.8%

Limoneira Co's EBITDA was -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 609.8% from the prior year.

Net Income
-$16.0M
YoY-307.1%

Limoneira Co reported -$16.0M in net income in fiscal year 2025. This represents a decrease of 307.1% from the prior year.

EPS (Diluted)
$-0.93
YoY-332.5%

Limoneira Co earned $-0.93 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 332.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$1.3M
YoY+11.8%
5Y CAGR-7.2%
10Y CAGR+35.7%

Limoneira Co held $1.3M in cash against $89.9M in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.30
YoY+0.0%
5Y CAGR+0.0%
10Y CAGR+5.2%

Limoneira Co paid $0.30 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding
18M
YoY+0.2%
5Y CAGR+0.5%
10Y CAGR+2.5%

Limoneira Co had 18M shares outstanding in fiscal year 2025. This represents an increase of 0.2% from the prior year.

Margins & Returns

Gross Margin
3.1%
YoY-10.9pp
5Y CAGR-1.3pp
10Y CAGR-20.0pp

Limoneira Co's gross margin was 3.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 10.9 percentage points from the prior year.

Operating Margin
-12.8%
YoY-9.6pp
5Y CAGR-1.2pp
10Y CAGR-17.3pp

Limoneira Co's operating margin was -12.8% in fiscal year 2025, reflecting core business profitability. This is down 9.6 percentage points from the prior year.

Net Margin
-10.0%
YoY-14.0pp
5Y CAGR-0.0pp
10Y CAGR-17.1pp

Limoneira Co's net profit margin was -10.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 14.0 percentage points from the prior year.

Return on Equity
-9.4%
YoY-13.6pp
5Y CAGR-0.8pp
10Y CAGR-15.5pp

Limoneira Co's ROE was -9.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 13.6 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

LMNR Income Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Revenue $23.9M+31.4% $18.2M-57.5% $42.8M-9.8% $47.5M+35.2% $35.1M+2.4% $34.3M-21.8% $43.9M-30.7% $63.3M
Cost of Revenue $23.2M+0.6% $23.0M-51.6% $47.6M+13.1% $42.0M+32.6% $31.7M-5.4% $33.5M-15.9% $39.8M-12.4% $45.4M
Gross Profit $768K+116.0% -$4.8M-1.6% -$4.7M-187.3% $5.4M+58.9% $3.4M+323.7% $806K-80.1% $4.0M-77.4% $17.9M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $5.4M+18.0% $4.6M-37.2% $7.3M+47.5% $5.0M-13.5% $5.7M-11.5% $6.5M+12.5% $5.8M-17.7% $7.0M
Operating Income -$21.7M-105.6% -$10.6M+4.8% -$11.1M-1659.4% -$630K+81.2% -$3.3M+37.4% -$5.3M-94.3% -$2.8M-130.6% $9.0M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax -$5.3M-95.9% -$2.7M+1.1% -$2.7M-1597.3% $182K-39.5% $301K+112.5% -$2.4M-847.5% $322K-89.3% $3.0M
Net Income -$21.4M-127.2% -$9.4M-8.5% -$8.7M-916.5% -$855K+74.6% -$3.4M-9.3% -$3.1M-65.4% -$1.9M-128.2% $6.6M
EPS (Diluted) $-1.20-126.4% $-0.53 N/A $-0.06+70.0% $-0.20-11.1% $-0.18 N/A $0.35

LMNR Balance Sheet

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Total Assets $293.8M-4.4% $307.5M-1.2% $311.1M+3.7% $299.9M+1.1% $296.6M-1.6% $301.4M+0.9% $298.8M-2.8% $307.3M
Current Assets $41.4M+59.2% $26.0M-35.8% $40.5M-12.6% $46.3M+55.2% $29.8M+4.8% $28.5M+10.1% $25.8M-27.2% $35.5M
Cash & Equivalents $891K-29.7% $1.3M-16.0% $1.5M-28.5% $2.1M+1.3% $2.1M+83.8% $1.1M-62.2% $3.0M+174.9% $1.1M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $12.3M+19.7% $10.3M-33.4% $15.4M-20.9% $19.5M+23.9% $15.8M-1.1% $15.9M+8.1% $14.7M-31.1% $21.4M
Goodwill $1.4M0.0% $1.4M-8.8% $1.5M+0.3% $1.5M-0.3% $1.5M+0.3% $1.5M-0.2% $1.5M-0.1% $1.5M
Total Liabilities $130.1M+2.5% $126.9M+5.5% $120.3M+10.6% $108.8M+5.5% $103.2M-0.8% $104.0M+8.0% $96.3M-5.2% $101.6M
Current Liabilities $24.7M+10.3% $22.4M-25.6% $30.1M+16.7% $25.8M-9.6% $28.5M+4.8% $27.2M-21.8% $34.8M-8.9% $38.2M
Long-Term Debt $93.7M+4.2% $89.9M+24.1% $72.5M+14.4% $63.3M+15.3% $54.9M-5.1% $57.9M+44.6% $40.0M0.0% $40.0M
Total Equity $152.9M-10.0% $169.8M-5.7% $180.0M-0.1% $180.3M-1.3% $182.7M-2.1% $186.5M-2.7% $191.7M-1.6% $194.9M
Retained Earnings -$33.4M-178.8% -$12.0M-1019.6% -$1.1M-111.8% $9.1M-20.4% $11.4M-29.7% $16.3M-21.9% $20.8M-13.8% $24.2M

LMNR Cash Flow Statement

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Operating Cash Flow -$4.5M+61.9% -$11.7M-1346.2% $942K+131.7% -$3.0M-133.2% $8.9M+169.1% -$12.9M-296.0% $6.6M-73.2% $24.6M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$10K+99.7% -$3.4M+59.9% -$8.5M-153.4% -$3.4M-11.2% -$3.0M+13.7% -$3.5M-39.5% -$2.5M+33.5% -$3.8M
Financing Cash Flow $3.9M-74.7% $15.3M+119.7% $6.9M+9.6% $6.3M+227.1% -$5.0M-134.3% $14.5M+766.3% -$2.2M+89.7% -$21.1M
Dividends Paid $0-100.0% $1.4M+0.3% $1.4M0.0% $1.4M+0.1% $1.4M0.0% $1.4M-0.1% $1.4M0.0% $1.4M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

LMNR Financial Ratios

Metric Q2'26 Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24
Gross Margin 3.2%+29.7pp -26.4%-15.4pp -11.1%-22.5pp 11.4%+1.7pp 9.7%+7.4pp 2.4%-6.9pp 9.2%-19.0pp 28.2%
Operating Margin -90.7%-32.7pp -58.0%-32.1pp -25.9%-24.5pp -1.3%+8.2pp -9.5%+6.1pp -15.6%-9.3pp -6.3%-20.5pp 14.2%
Net Margin -89.5%-37.7pp -51.8%-31.5pp -20.3%-18.5pp -1.8%+7.8pp -9.6%-0.6pp -9.0%-4.7pp -4.2%-14.6pp 10.4%
Return on Equity -14.0%-8.5pp -5.5%-0.7pp -4.8%-4.4pp -0.5%+1.4pp -1.8%-0.2pp -1.7%-0.7pp -1.0%-4.3pp 3.4%
Return on Assets -7.3%-4.2pp -3.1%-0.3pp -2.8%-2.5pp -0.3%+0.8pp -1.1%-0.1pp -1.0%-0.4pp -0.6%-2.8pp 2.1%
Current Ratio 1.68+0.5 1.16-0.2 1.35-0.5 1.80+0.7 1.050.0 1.05+0.3 0.74-0.2 0.93
Debt-to-Equity 0.61+0.1 0.53+0.1 0.40+0.1 0.35+0.1 0.300.0 0.31+0.1 0.210.0 0.21
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Limoneira Co (LMNR) reported $159.7M in total revenue for fiscal year 2025. This represents a -16.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Limoneira Co (LMNR) revenue declined by 16.6% year-over-year, from $191.5M to $159.7M in fiscal year 2025.

No, Limoneira Co (LMNR) reported a net income of -$16.0M in fiscal year 2025, with a net profit margin of -10.0%.

Limoneira Co (LMNR) reported diluted earnings per share of $-0.93 for fiscal year 2025. This represents a -332.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Limoneira Co (LMNR) had EBITDA of -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Limoneira Co (LMNR) had $1.3M in cash and equivalents against $89.9M in long-term debt.

Limoneira Co (LMNR) had a gross margin of 3.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Limoneira Co (LMNR) had an operating margin of -12.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Limoneira Co (LMNR) had a net profit margin of -10.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Limoneira Co (LMNR) paid $0.30 per share in dividends during fiscal year 2025.

Limoneira Co (LMNR) has a return on equity of -9.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Limoneira Co (LMNR) generated -$6.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Limoneira Co (LMNR) had $307.5M in total assets as of fiscal year 2025, including both current and long-term assets.

Limoneira Co (LMNR) had 18M shares outstanding as of fiscal year 2025.

Limoneira Co (LMNR) had a current ratio of 1.16 as of fiscal year 2025, which is considered adequate.

Limoneira Co (LMNR) had a debt-to-equity ratio of 0.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Limoneira Co (LMNR) had a return on assets of -5.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Limoneira Co (LMNR) had $1.3M in cash against an annual operating cash burn of $6.0M. This gives an estimated cash runway of approximately 3 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Limoneira Co (LMNR) has an Altman Z-Score of 1.39, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Limoneira Co (LMNR) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Limoneira Co (LMNR) has an earnings quality ratio of 0.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Limoneira Co (LMNR) scores 34 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top